Loading insider details...
Beta
Latest Form 4 (Aug 10, 2026): Purchase of 700 BLSM shares, $11.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 10, 2026 | BlossomHill Therapeutics, Inc. (BLSM) | Purchase | 700 | $11.2K |
| May 22, 2026 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/Award | 15,000 | n/a |
| May 23, 2025 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/Award | 15,000 | n/a |
| Feb 20, 2025 | Equillium, Inc. (EQ) | Grant/Award | 70,000 | n/a |
| Jan 24, 2025 | Equillium, Inc. (EQ) | Sale | 10,000 | $6.5K |
| Jan 6, 2025 | Equillium, Inc. (EQ) | Grant/Award | 15,000 | $8.1K |
| Nov 15, 2024 | Equillium, Inc. (EQ) | Sale | 10,000 | $7.0K |
| Sep 27, 2024 | Equillium, Inc. (EQ) | Sale | 10,000 | $8.1K |
| Aug 14, 2024 | ACTUATE THERAPEUTICS, INC. (ACTU) | Grant/Award | 30,000 | n/a |
| Jul 18, 2024 | Equillium, Inc. (EQ) | Sale | 10,000 | $8.7K |